Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target

SIMPLE SUMMARY: Small cell lung cancer (SCLC) is a fatal malignant tumor with a poor prognosis for patients who relapse after first-line treatment. There are few effective treatments for SCLC patients with relapse. Elucidation of the molecular network related to treatment resistance is an important...

Descripción completa

Detalles Bibliográficos
Autores principales: Misono, Shunsuke, Mizuno, Keiko, Suetsugu, Takayuki, Tanigawa, Kengo, Nohata, Nijiro, Uchida, Akifumi, Sanada, Hiroki, Okada, Reona, Moriya, Shogo, Inoue, Hiromasa, Seki, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998124/
https://www.ncbi.nlm.nih.gov/pubmed/33801812
http://dx.doi.org/10.3390/cancers13061187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998124/
https://www.ncbi.nlm.nih.gov/pubmed/33801812
http://dx.doi.org/10.3390/cancers13061187

Ejemplares similares